SCHEMBL6599669

SCHEMBL6599669

O=C(c1ccc(Br)o1)N1CCNCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 4/20 0.61
CHRNB4 P30926 4/20 0.61
CHRNA3 P32297 4/20 0.61
CHRNA4 P43681 4/20 0.61
SCN5A Q14524 1/20 0.57
SCN2A Q99250 1/20 0.57
SCN10A Q9Y5Y9 1/20 0.57
TSHR P16473 1/20 0.55
ALDH1A1 P00352 4/20 0.53
SETD7 Q8WTS6 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
POLB P06746 1/20 0.52
CHRNA7 P36544 2/20 0.51
LMNA P02545 2/20 0.50
SIGMAR1 Q99720 1/20 0.49
KDM4E B2RXH2 1/20 0.48
MAPT P10636 1/20 0.48
NPC1 O15118 1/20 0.48
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1763285 0.98 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA4SCN5A
SCHEMBL3153541 0.84 TSHR (0.58) CHRNB2CHRNB4CHRNA3CHRNA4TSHR
SCHEMBL3150435 0.81 ALDH1A1 (0.59) CHRNB2CHRNB4CHRNA3CHRNA4TSHR
SCHEMBL6035071 0.81 TSHR (0.59) CHRNB2CHRNB4CHRNA3CHRNA4TSHR
SCHEMBL27506976 0.80 TSHR (0.55) CHRNB2CHRNB4CHRNA3CHRNA4TSHR
SCHEMBL1771402 0.80 KMT2A (0.59) CHRNB2CHRNB4CHRNA3CHRNA4TSHR
Ethylene SCHEMBL8379882 0.78 TSHR (0.52) CHRNB2CHRNB4CHRNA3CHRNA4TSHR
SCHEMBL6598093 0.76 TSHR (0.54) CHRNB2CHRNB4CHRNA3CHRNA4TSHR
SCHEMBL585202 0.76 CHRNA4 (1.00) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL6427074 0.75 ALDH1A1 (0.72) CHRNA4SCN5ASCN2ASCN10AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1414801-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 AstraZeneca AB (SE) 2004-05-06 EP claimed
WO-2003004472-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 ASTRAZENECA AB (SE) 2003-01-16 WO claimed